Top compounds associated with response to OR8I2


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.042 0.2
mRNA ZM-447439 GDSC1000 pan-cancer AAC -0.045 0.2
mRNA BI-2536 CTRPv2 pan-cancer AAC -0.038 0.2
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.037 0.2
mRNA Vandetanib CTRPv2 pan-cancer AAC -0.043 0.2
mRNA BMS-536924 GDSC1000 pan-cancer AAC -0.039 0.2
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.042 0.2
mRNA trifluoperazine CTRPv2 pan-cancer AAC -0.046 0.2
mRNA FR-180204 GDSC1000 pan-cancer AAC -0.041 0.2
mRNA CP466722 GDSC1000 pan-cancer AAC -0.036 0.2
Download CSV